MOTS-c molecular structure
MOTS-c molecular structure
Experimental
Longevity

MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA type-c

MW

2174.50 Da

Formula

C101H152N28O25S2

CAS

1627580-64-6

Routes

1 route

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino acid mitochondrial-derived peptide encoded in the 12S rRNA gene of mitochondrial DNA. Discovered in 2015 by Dr. Pinchas Cohen's laboratory at USC, MOTS-c was the first mitochondrial-encoded peptide shown to have profound metabolic effects — functioning as an exercise mimetic that enhances insulin sensitivity, promotes fat oxidation, and improves metabolic homeostasis. MOTS-c's discovery expanded the concept of mitochondrial-derived peptides (MDPs) as a new class of signaling molecules. Remarkably, MOTS-c translocates to the nucleus during metabolic stress, directly regulating gene expression — the first example of a mitochondrial-encoded peptide acting as a nuclear transcription regulator. It declines with age, suggesting a role in age-related metabolic dysfunction.

Research Use OnlyFor educational and research purposes only

Research Applications

Exercise Mimetic

MOTS-c reproduces many metabolic effects of exercise: enhanced fat oxidation, improved insulin sensitivity, increased mitochondrial function. Research positions it as a potential treatment for sedentary-related metabolic disease.

Type 2 Diabetes and Insulin Resistance

Preclinical studies show MOTS-c restores insulin sensitivity in diet-induced obesity models, reduces fasting glucose, and improves glucose tolerance — effects comparable to exercise intervention.

Aging and Longevity

MOTS-c levels decline with age. Supplementation in aged mice improves physical performance, metabolic health, and healthspan, suggesting potential anti-aging applications.

Obesity

MOTS-c prevents diet-induced obesity in animal models through enhanced energy expenditure and fat oxidation, without reducing food intake.

Osteoporosis

Recent research shows MOTS-c promotes osteoblast differentiation and bone formation through AMPK-dependent pathways.

Mechanism of Action

MOTS-c activates AMPK (the master energy sensor) by increasing the AMP/ATP ratio through inhibition of the folate/methionine cycle (reducing de novo purine synthesis). Activated AMPK enhances fatty acid oxidation, glucose uptake, and mitochondrial biogenesis. Uniquely, MOTS-c translocates to the nucleus during metabolic stress, where it interacts with ARE (antioxidant response element) regulators and modulates stress-responsive gene expression. It enhances skeletal muscle glucose uptake independently of insulin through AMPK-mediated GLUT4 translocation.

Biological Pathways

AMPK activation through metabolic shift (folate cycle inhibition). AMPK/ACC/CPT-1 for fat oxidation. AMPK/GLUT4 for insulin-independent glucose uptake. Nuclear translocation for ARE-mediated gene regulation. PGC-1α for mitochondrial biogenesis.

Dosage Information

Typical dosage ranges for research applications. Always verify with current literature.
Typical Dose
10,000 mcg
Dose Range
5,000 - 15,000 mcg
Frequency
2-3 times weekly, fasted morning or 30-60 min before exercise; 2-4 week cycles, 2-3 cycles/year
Dosage Calculator
Calculate precise peptide dosages based on your reconstitution parameters
Dosage calculation parameters
Vial size in milligrams
Reconstitution volume in milliliters
Body weight input
Recommended dose per kg
mcg/kg
Desired dose input
mcg

Calculation Results

Concentration
2.5 mg/ml
Dose Volume
0.1 ml0.100 ml
Insulin Syringe
10 units
Doses per Vial
2020 doses @ 250 mcg

Syringe Fill Level (100u syringe)

05010010.0uunits
0u10.0 / 100 units (10%)100u

Protocols

Comprehensive Longevity Stack
Advanced
Anti-Aging
3-6 months

Multi-peptide anti-aging protocol combining telomerase activation, mitochondrial support, and GH optimization.

Dosage
Epithalon: 1mg daily, MOTS-c: 10mg 2x/week, NAD+: 500mg daily, CJC/Ipa: 200mcg each daily
Frequency
Daily or as specified per peptide
Cycle
Epithalon: 50-day course yearly. MOTS-c: Ongoing 2x/week. NAD+: Daily. CJC/Ipa: 5 on/2 off.
Stacking Notes
Comprehensive approach targeting multiple aging pathways. Requires significant commitment and cost.

Warning: Very advanced protocol. Consider blood work monitoring.

Stability & Storage

MOTS-c is supplied as lyophilized powder. Store at -20°C for long-term stability. Reconstitute with bacteriostatic water or sterile saline. Use within 21 days at 2-8°C. In-vivo half-life is relatively short, necessitating daily or frequent administration.

Side Effects & Precautions

Limited human safety data as MOTS-c is primarily in preclinical research. No significant toxicity in animal studies. Theoretical risk of excessive AMPK activation affecting cellular energy balance. Potential for hypoglycemia in combination with diabetes medications.

Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.

Regulatory Status

Experimental

Investigational. Preclinical and early translational research. Not approved by any regulatory authority. Not WADA-prohibited (but classification may evolve as clinical development progresses).

Research Studies

MOTS-c: A Mitochondrial-Encoded Peptide That Regulates Metabolism

Lee C, Zeng J, Drew BG, et al.

Cell Metabolism
2015
View Source

MOTS-c Nuclear Translocation During Metabolic Stress

Kim KH, Son JM, Benayoun BA, Lee C.

Cell Metabolism
2018
View Source

MOTS-c as an Exercise Mimetic

Reynolds JC, Lai RW, Woodhead JST, et al.

Cell Metabolism
2021
View Source
Dosage Calculator
Calculate reconstitution volumes and injection amounts for MOTS-c.
Explore More
Explore more peptides in the Longevity category and related research.